Cattani: With 30% tariffs, the pharmaceutical industry loses 4 billion.

"It is estimated that tariffs of 30% would lead to a loss of more than 4 billion euros". He said said the president of Farmindustria Marcello Cattani, speaking in an interview with La Stampa on the consequences that the US tariffs on Italian pharmaceuticals. In case of no agreement "the first damage would be for the U.S. economy and the health of Americans. It would cause a significant drop in GDP. Forecasts say that some decimal places to some points. And there would be a shift of investments towards China, a sharp increase in prices and a shortage of medicines". For Cattani "in a system privatized, insurance would also suffer increases. Without count the weight of the devalued dollar. And let's face it: today, it is more It's easy for everyone to have drones but the drugs can't be found everywhere". In the drugstores, in the immediate future, "they may be missing large quantities of antibiotics, antihypertensives, neuroleptics, immuno-oncology drugs and drugs for the treatment of rare diseases, as well as to various lifesavers". As for the possibility of bringing the production In the United States, Cattani says: "Several multinationals have already announced investments: Sanofi, Novartis, AstraZeneca, Roche. But it will take at least 3 or 4 years for to set up a production facility in the USA". In Italy "someone is thinking about it seriously from a perspective of internationalization". In terms of numbers "more or less a dozen companies are of adequate size. It is evaluated how and in what times. But there's nothing concrete yet."